Soya Crisps | whatsinit

About

What it is and where it shows up.

Soya crisps are extruded, puffed snack pieces made primarily from soy protein concentrate or soy protein isolate, often combined with rice flour, salt, and a small amount of fat; they are used as a high-protein ingredient in snack bars, cereals, trail mixes, and protein products. They provide a crunchy texture and a concentrated source of plant protein (typically 60–90% protein by dry weight) while contributing minimal fat and carbohydrate.

Safety summary

The regulatory and scientific consensus.

Soya crisps are generally recognised as safe for the general adult population; no ADI has been established, and regulatory bodies including the FDA and EFSA have found no safety concerns with soy protein at typical food intake levels. Soy is one of the major recognised food allergens worldwide and must be declared on labels in the EU, US, UK, India, and most other jurisdictions. The isoflavone content of soy protein products may interact with hormone-sensitive conditions, though evidence at normal dietary intake levels is not conclusive.

Regulatory landscape

What food-safety regulators have decided.

Jurisdiction	Status	Note
FSANZ (Food Standards Australia New Zealand) (Australia)	Approved	Soy and soy products are approved food ingredients under the Australia New Zealand Food Standards Code. Soy is a declared allergen under Standard 1.2.3 and must be declared on food labels.source
EFSA (European Food Safety Authority) (European Union)	Approved	Soya and products thereof are listed as one of the 14 major allergens in Annex II of Regulation (EU) No 1169/2011 on food information to consumers; mandatory declaration on all food labels is required. No specific maximum use level is set for soy protein or soya crisps as a food ingredient.source
Food Standards Agency (FSA) / Food Standards Scotland (FSS) (United Kingdom)	Approved	Soya is one of the 14 major allergens under UK food allergen labelling regulations (retained from EU Regulation 1169/2011 post-Brexit). No specific maximum use level for soya crisps as an ingredient.source
FSSAI (Food Safety and Standards Authority of India) (India)	Approved	Soy protein products are permitted ingredients under the Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011. Soy is identified as a known allergen and must be declared on labels per FSSAI allergen labelling regulations.source

Who should approach with care

Whose guidance would steer them away.

Nut Allergy — Soy is one of the 14 major recognised food allergens globally; individuals with soy allergy can experience reactions ranging from mild urticaria to anaphylaxis and must avoid all soy-containing products.

Infants — Soy-based formulas and soy protein products for infants should only be used on medical or dietitian advice, as phytoestrogens (isoflavones) in soy may have developmental effects and cow's milk or breast milk is generally preferred.

Thyroid Disease — Soy isoflavones can interfere with thyroid hormone synthesis and the absorption of thyroid medication (levothyroxine); individuals with hypothyroidism should consume soy products cautiously and not close to medication timing.

Pregnancy — While moderate dietary soy intake is generally considered safe in pregnancy, high-dose soy isoflavone supplements are not recommended due to uncertain hormonal effects; soya crisps as a food ingredient at typical serving sizes are unlikely to pose risk.

Ibs — Soy protein products can contain fermentable oligosaccharides (FODMAPs) that may exacerbate gastrointestinal symptoms such as bloating and discomfort in individuals with irritable bowel syndrome.

Research citations

The sources behind this verdict.

1FDA. 21 CFR 172.866 — Soy Protein Isolate. accessdata.fda.gov
2NCCIH. Soy: Usefulness and Safety. nccih.nih.gov
3other. High Protein Snack Product (US Patent 7556836). image-ppubs.uspto.gov
4PubMed. Assessment of genetically modified soybean MON 87751 for food and feed uses under Regulation (EC) No 1829/2003, 2018. efsa.europa.eu
5FDA. Soy Protein and Coronary Heart Disease — Proposed Rule (Docket No. FDA-2017-N-0763), 2017. federalregister.gov

Independently researched5 citations